We have performed localised proton magnetic resonance spectroscopy (MR
S) of the brain on four patients with X-linked adrenoleukodystrophy (X
-ALD). The spectrum is characterised at the beginning of the disease b
y a decrease in N-acetylaspartate and phosphocreatine-creatine content
. Choline is strongly increased, and lactate can be detected in some c
ases. A proton signal from the CH2 groups borne by free intracellular
very long chain fatty acids can also be observed. Later in the disease
, the levels of all metabolites, in particular NAA, decrease significa
ntly. The progression of neurometabolism documented by MRS correlates
well with MRI and clinical progression on follow-up study. In one case
, the metabolic profile recorded by proton MRS was abnormal before any
change occurred on MRI. Proton MRS of the brain might be the method o
f choice for monitoring patients with X-ALD, to screen presumed cases
and to study the effects of treatment.